It consists of a distinct disease from myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2. This evidence concerns the gene FGFR1 and lymphoid neoplasm.